United States Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2024-2032

United States Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A21738

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   United States Biomarkers Market - Introduction

    4.1    Overview
    4.2    Market Dynamics
    4.3    Industry Trends
    4.4    Competitive Intelligence
5   United States Biomarkers Market Landscape
    5.1    Historical and Current Market Trends (2018-2023)
    5.2    Market Forecast (2024-2032)
6   United States Biomarkers Market - Breakup by Product
    6.1    Consumables
        6.1.1 Overview
        6.1.2 Historical and Current Market Trends (2018-2023)
        6.1.3 Market Forecast (2024-2032)
    6.2    Services
        6.2.1 Overview
        6.2.2 Historical and Current Market Trends (2018-2023)
        6.2.3 Market Forecast (2024-2032)
    6.3    Software
        6.3.1 Overview
        6.3.2 Historical and Current Market Trends (2018-2023)
        6.3.3 Market Forecast (2024-2032)
7   United States Biomarkers Market - Breakup by Type
    7.1    Efficacy Biomarkers
        7.1.1 Overview
        7.1.2 Historical and Current Market Trends (2018-2023)
        7.1.3 Market Forecast (2024-2032)
    7.2    Safety Biomarkers
        7.2.1 Overview
        7.2.2 Historical and Current Market Trends (2018-2023)
        7.2.3 Market Forecast (2024-2032)
    7.3    Validation Biomarkers
        7.3.1 Overview
        7.3.2 Historical and Current Market Trends (2018-2023)
        7.3.3 Market Forecast (2024-2032)
8   United States Biomarkers Market - Breakup by Disease
    8.1    Cancer
        8.1.1 Overview
        8.1.2 Historical and Current Market Trends (2018-2023)
        8.1.3 Market Forecast (2024-2032)
    8.2    Cardiovascular Disorders
        8.2.1 Overview
        8.2.2 Historical and Current Market Trends (2018-2023)
        8.2.3 Market Forecast (2024-2032)
    8.3    Neurological Disorders
        8.3.1 Overview
        8.3.2 Historical and Current Market Trends (2018-2023)
        8.3.3 Market Forecast (2024-2032)
    8.4    Immunological Disorders
        8.4.1 Overview
        8.4.2 Historical and Current Market Trends (2018-2023)
        8.4.3 Market Forecast (2024-2032)
    8.5    Renal Disorders
        8.5.1 Overview
        8.5.2 Historical and Current Market Trends (2018-2023)
        8.5.3 Market Forecast (2024-2032)
    8.6    Others
        8.6.1 Historical and Current Market Trends (2018-2023)
        8.6.2 Market Forecast (2024-2032)
9   United States Biomarkers Market - Breakup by Application
    9.1    Diagnostics
        9.1.1 Overview
        9.1.2 Historical and Current Market Trends (2018-2023)
        9.1.3 Market Forecast (2024-2032)
    9.2    Drug Discovery and Development
        9.2.1 Overview
        9.2.2 Historical and Current Market Trends (2018-2023)
        9.2.3 Market Forecast (2024-2032)
    9.3    Personalized Medicine
        9.3.1 Overview
        9.3.2 Historical and Current Market Trends (2018-2023)
        9.3.3 Market Forecast (2024-2032)
    9.4    Others
        9.4.1 Historical and Current Market Trends (2018-2023)
        9.4.2 Market Forecast (2024-2032)
10  United States Biomarkers Market - Breakup by End User
    10.1    Pharmaceutical and Biotechnology Companies
        10.1.1 Overview
        10.1.2 Historical and Current Market Trends (2018-2023)
        10.1.3 Market Forecast (2024-2032)
    10.2    Diagnostic and Research Laboratories
        10.2.1 Overview
        10.2.2 Historical and Current Market Trends (2018-2023)
        10.2.3 Market Forecast (2024-2032)
    10.3    Hospitals and Specialty Clinics
        10.3.1 Overview
        10.3.2 Historical and Current Market Trends (2018-2023)
        10.3.3 Market Forecast (2024-2032)
    10.4    Others
        10.4.1 Historical and Current Market Trends (2018-2023)
        10.4.2 Market Forecast (2024-2032) 
11  United States Biomarkers Market – Breakup by Region
     11.1    Northeast
        11.1.1 Overview
        11.1.2 Historical and Current Market Trends (2018-2023)
        11.1.3 Market Breakup by Product
        11.1.4 Market Breakup by Type
        11.1.5 Market Breakup by Disease
        11.1.6 Market Breakup by Application
        11.1.7 Market Breakup by End User
        11.1.8 Key Players
        11.1.9 Market Forecast (2024-2032)
    11.2    Midwest
        11.2.1 Overview
        11.2.2 Historical and Current Market Trends (2018-2023)
        11.2.3 Market Breakup by Product
        11.2.4 Market Breakup by Type
        11.2.5 Market Breakup by Disease
        11.2.6 Market Breakup by Application
        11.2.7 Market Breakup by End User
        11.2.8 Key Players
        11.2.9 Market Forecast (2024-2032)
    11.3    South
        11.3.1 Overview
        11.3.2 Historical and Current Market Trends (2018-2023)
        11.3.3 Market Breakup by Product
        11.3.4 Market Breakup by Type
        11.3.5 Market Breakup by Disease
        11.3.6 Market Breakup by Application
        11.3.7 Market Breakup by End User
        11.3.8 Key Players
        11.3.9 Market Forecast (2024-2032)   
    11.4    West
        11.4.1 Overview
        11.4.2 Historical and Current Market Trends (2018-2023)
        11.4.3 Market Breakup by Product
        11.4.4 Market Breakup by Type
        11.4.5 Market Breakup by Disease
        11.4.6 Market Breakup by Application
        11.4.7 Market Breakup by End User
        11.4.8 Key Players
        11.4.9 Market Forecast (2024-2032)
12  United States Biomarkers Market – Competitive Landscape
    12.1    Overview
    12.2    Market Structure
    12.3    Market Player Positioning
    12.4    Top Winning Strategies
    12.5    Competitive Dashboard
    12.6    Company Evaluation Quadrant
13  Profiles of Key Players
    13.1    Company A 
        13.1.1 Business Overview
        13.1.2 Services Offered
        13.1.3 Business Strategies
        13.1.4 SWOT Analysis
        13.1.5 Major News and Events
    13.2    Company B
        13.2.1 Business Overview
        13.2.2 Services Offered
        13.2.3 Business Strategies
        13.2.4 SWOT Analysis
        13.2.5 Major News and Events
    13.3    Company C
        13.3.1 Business Overview
        13.3.2 Services Offered
        13.3.3 Business Strategies
        13.3.4 SWOT Analysis
        13.3.5 Major News and Events
    13.4    Company D 
        13.4.1 Business Overview
        13.4.2 Services Offered
        13.4.3 Business Strategies
        13.4.4 SWOT Analysis
        13.4.5 Major News and Events
    13.5    Company E
        13.5.1 Business Overview
        13.5.2 Services Offered
        13.5.3 Business Strategies
        13.5.4 SWOT Analysis
        13.5.5 Major News and Evens

Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

14  United States Biomarkers Market - Industry Analysis
    14.1    Drivers, Restraints, and Opportunities
        14.1.1 Overview
        14.1.2 Drivers
        14.1.3 Restraints
        14.1.4 Opportunities
    14.2   Porters Five Forces Analysis
        14.2.1 Overview
        14.2.2 Bargaining Power of Buyers
        14.2.3 Bargaining Power of Suppliers
        14.2.4 Degree of Competition
        14.2.5 Threat of New Entrants
        14.2.6 Threat of Substitutes
    14.3    Value Chain Analysis
15  Appendix

United States Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials